Related references
Note: Only part of the references are listed.Type 1 diabetes, obesity and PCOS: Is type 1 stepping into the shoes of type 2 diabetes?
Ethel Codner
CLINICAL ENDOCRINOLOGY (2021)
Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications
Anita Jeyam et al.
DIABETES CARE (2021)
Efficacy and safety of adding sotagliflozin, a dual sodium-glucose co-transporter (SGLT)1 and SGLT2 inhibitor, to optimized insulin therapy in adults with type 1 diabetes and baseline body mass index ≥ 27 kg/m2
Thomas Danne et al.
DIABETES OBESITY & METABOLISM (2021)
Impact of routine clinic measurement of serum C-peptide in people with a clinician-diagnosis of type 1 diabetes
Evgenia Foteinopoulou et al.
DIABETIC MEDICINE (2021)
The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Richard I. G. Holt et al.
DIABETES CARE (2021)
Adult-Onset Type 1 Diabetes: Current Understanding and Challenges
R. David Leslie et al.
DIABETES CARE (2021)
Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes
Dina Mansour Aly et al.
NATURE GENETICS (2021)
The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function
Ruth L. M. Cordiner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Residual beta cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia
Rose A. Gubitosi-Klug et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
The Role of Incretins on Insulin Function and Glucose Homeostasis
Jens Juul Holst et al.
ENDOCRINOLOGY (2021)
Early Impairment of Insulin Sensitivity, β-Cell Responsiveness, and Insulin Clearance in Youth with Stage 1 Type 1 Diabetes
Alfonso Galderisi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?
Claire L. Meek et al.
DIABETES CARE (2021)
Latent Autoimmune Diabetes of Adults (LADA) Is Likely to Represent a Mixed Population of Autoimmune (Type 1) and Nonautoimmune (Type 2) Diabetes
Angus G. Jones et al.
DIABETES CARE (2021)
Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes
Taylor M. Triolo et al.
JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2021)
The utility of assessing C-peptide in patients with insulin-treated type 2 diabetes: a cross-sectional study
Tuccinardi Dario et al.
ACTA DIABETOLOGICA (2021)
The Role of Incretins on Insulin Function and Glucose Homeostasis
Jens Juul Holst et al.
ENDOCRINOLOGY (2021)
Early Impairment of Insulin Sensitivity, beta-Cell Responsiveness, and Insulin Clearance in Youth with Stage 1 Type 1 Diabetes
Alfonso Galderisi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes
Manuela Battaglia et al.
DIABETES CARE (2020)
Fasting C-peptide, a biomarker for hypoglycaemia risk in insulin-naive people with type 2 diabetes initiating basal insulin glargine 100 U/mL
Wolfgang Landgraf et al.
DIABETES OBESITY & METABOLISM (2020)
Impact of baseline characteristics and beta-cell function on the efficacy and safety of subcutaneous once-weekly semaglutide: A patient-level, pooled analysis of the SUSTAIN 1-5 trials
Vanita R. Aroda et al.
DIABETES OBESITY & METABOLISM (2020)
The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening
Laura M. Jacobsen et al.
DIABETOLOGIA (2020)
2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse et al.
DIABETES CARE (2020)
Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes
Fraser W. Gibb et al.
DIABETOLOGIA (2020)
H for Heterogeneity in the Algorithm for Type 2 Diabetes Management
Pieralice Silvia et al.
CURRENT DIABETES REPORTS (2020)
Impact of obesity on the increasing incidence of type 1 diabetes
Raffaella Buzzetti et al.
DIABETES OBESITY & METABOLISM (2020)
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)
Ernesto Maddaloni et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Decline Pattern of Beta-cell Function in Adult-onset Latent Autoimmune Diabetes: an 8-year Prospective Study
Xia Li et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
High residual C-peptide likely contributes to glycemic control in type 1 diabetes
Michael R. Rickels et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Benefit/risk profile of dapagliflozin 5 mg in theDEPICT-1 and-2 trials in individuals with type 1 diabetes and body mass index ≥27 kg/m2
Chantal Mathieu et al.
DIABETES OBESITY & METABOLISM (2020)
Adult-onset autoimmune diabetes in 2020: An update
Ernesto Maddaloni et al.
MATURITAS (2020)
Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel
Raffaella Buzzetti et al.
DIABETES (2020)
Switching From Insulin Bolus Treatment to GLP-1 RAs Added to Continued Basal Insulin in People With Type 2 Diabetes on Basal-Bolus Insulin
Geremia B. Bolli et al.
DIABETES CARE (2020)
The clinical consequences of heterogeneity within and between different diabetes types
Maria J. Redondo et al.
DIABETOLOGIA (2020)
Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
Sara Sokooti et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression
Giovanni Musso et al.
PLOS MEDICINE (2020)
A Plant-Based Meal Stimulates Incretin and Insulin Secretion More Than an Energy- and Macronutrient-Matched Standard Meal in Type 2 Diabetes: A Randomized Crossover Study
Hana Kahleova et al.
NUTRIENTS (2019)
Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85)
Ernesto Maddaloni et al.
DIABETES OBESITY & METABOLISM (2019)
Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?
S. M. Marren et al.
DIABETIC MEDICINE (2019)
Persistent C-peptide secretion in Type 1 diabetes and its relationship to the genetic architecture of diabetes
Paul M. McKeigue et al.
BMC MEDICINE (2019)
Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years
Anita Lynam et al.
BMJ OPEN (2019)
A Type 1 Diabetes Genetic Risk Score Can Identify Patients With GAD65 Autoantibody-Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy
Anita L. Grubb et al.
DIABETES CARE (2019)
Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes
Nitesh D. Kuhadiya et al.
DIABETES OBESITY & METABOLISM (2019)
Inappropriate glucagon and GLP-1 secretion in individuals with long-standing type 1 diabetes: effects of residual C-peptide
Charles Thivolet et al.
DIABETOLOGIA (2019)
Effect of once weekly dulaglutide by baseline beta-cell function in people with type 2 diabetes in the AWARD programme
Chantal Mathieu et al.
DIABETES OBESITY & METABOLISM (2018)
Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at Home
Ruben H. Willemsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM
Sabine Zenz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables
Emma Ahlqvist et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
Karen D. Corbin et al.
ENDOCRINE REVIEWS (2018)
β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis
Carmella Evans-Molina et al.
JCI INSIGHT (2018)
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
Suzy V. Hope et al.
DIABETOLOGIA (2018)
Effect of meal composition on postprandial glucagon-like peptide-1, insulin, glucagon, C-peptide, and glucose responses in overweight/obese subjects
Meena Shah et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
C-peptide and the pathophysiology of microvascular complications of diabetes
J. Wahren
JOURNAL OF INTERNAL MEDICINE (2017)
Adult-onset autoimmune diabetes: current knowledge and implications for management
Raffaella Buzzetti et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Metabolic risk profiles in diabetes stratified according to age at onset, islet autoimmunity and fasting C-peptide
Mette Wod et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Implementing a Reference Measurement System for C-Peptide: An Addendum
Randie R. Little et al.
CLINICAL CHEMISTRY (2017)
Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes
C. Guglielmi et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Characteristics of the pre-diabetic period in children with high risk of type 1 diabetes recruited from the general Swedish populationThe ABIS study
Linda Akerman et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index
Riccardo C. Bonadonna et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2017)
C-peptide: A predictor of cardiovascular mortality in subjects with established atherosclerotic disease
Marina Cardellini et al.
DIABETES & VASCULAR DISEASE RESEARCH (2017)
Implementing a Reference Measurement System for C-Peptide: Successes and Lessons Learned
Randie R. Little et al.
CLINICAL CHEMISTRY (2017)
Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
Angus G. Jones et al.
DIABETES CARE (2016)
Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment
R. David Leslie et al.
DIABETOLOGIA (2016)
Reduced β-cell function in early preclinical type 1 diabetes
Maarit K. Koskinen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes
Emily K. Sims et al.
DIABETES CARE (2016)
Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized Trial
Chantal Mathieu et al.
DIABETES CARE (2016)
C-Peptide-Based Index Is More Related to Incident Type 2 Diabetes in Non-Diabetic Subjects than Insulin-Based Index
Jong-Dai Kim et al.
ENDOCRINOLOGY AND METABOLISM (2016)
Relationship between serum C-peptide level and diabetic retinopathy according to estimated glomerular filtration rate in patients with type 2 diabetes
Jin Ook Chung et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2015)
Combination immunotherapies for type 1 diabetes mellitus
Paolo Pozzilli et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9
Marta Hernandez et al.
BMC ENDOCRINE DISORDERS (2015)
Latent Autoimmune Diabetes in Adults With Low-Titer GAD Antibodies: Similar Disease Progression With Type 2 Diabetes A Nationwide, Multicenter Prospective Study (LADA China Study 3)
Lingjiao Liu et al.
DIABETES CARE (2015)
Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
Asa K. Davis et al.
DIABETES CARE (2015)
Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement
Ernesto Maddaloni et al.
PLOS ONE (2015)
BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children
A. Lauria et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2015)
Impact of C-Peptide Preservation on Metabolic and Clinical Outcomes in the Diabetes Control and Complications Trial
John M. Lachin et al.
DIABETES (2014)
Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
A. Barker et al.
DIABETES OBESITY & METABOLISM (2014)
Similar weight-adjusted insulin secretion and insulin sensitivity in short-duration late autoimmune diabetes of adulthood (LADA) and Type 2 diabetes: Action LADA 8
C. B. Juhl et al.
DIABETIC MEDICINE (2014)
High GADA titer increases the risk of insulin requirement in LADA patients: a 7-year follow-up (NIRAD study 7)
Simona Zampetti et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
The many faces of diabetes: a disease with increasing heterogeneity
Tiinamaija Tuomi et al.
LANCET (2014)
Frequency, Immunogenetics, and Clinical Characteristics of Latent Autoimmune Diabetes in China (LADA China Study) A Nationwide, Multicenter, Clinic-Based Cross-Sectional Study
Zhiguang Zhou et al.
DIABETES (2013)
Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
Jay M. Sosenko et al.
DIABETES (2013)
C-Peptide Levels Are Associated With Mortality and Cardiovascular Mortality in Patients Undergoing Angiography The LURIC study
Nikolaus Marx et al.
DIABETES CARE (2013)
Lessons From the Mixed-Meal Tolerance Test Use of 90-minute and fasting C-peptide in pediatric diabetes
Rachel E. J. Besser et al.
DIABETES CARE (2013)
The clinical utility of C-peptide measurement in the care of patients with diabetes
A. G. Jones et al.
DIABETIC MEDICINE (2013)
Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes
Tadashi Iwao et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2013)
Association between serum C-peptide levels and chronic microvascular complications in Korean type 2 diabetic patients
Bo-Yeon Kim et al.
ACTA DIABETOLOGICA (2012)
Development of SI-traceable C-peptide certified reference material NMIJ CRM 6901-a using isotope-dilution mass spectrometry-based amino acid analyses
Tomoya Kinumi et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment
Michinori Takabe et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
C-peptide and the risk for incident complications and mortality in type 2 diabetic patients: a retrospective cohort study after a 14-year follow-up
S. Bo et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6)
Simona Zampetti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
C-Peptide: A New Mediator of Atherosclerosis in Diabetes
Dusica Vasic et al.
MEDIATORS OF INFLAMMATION (2012)
LADA prevalence estimation and insulin dependency during follow-up
Yongsoo Park et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Proinsulin-to-C-peptide ratio versus proinsulin-to-insulin ratio in the prediction of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS)
R. C. Loopstra-Masters et al.
DIABETOLOGIA (2011)
Impaired Regulation of the Incretin Effect in Patients with Type 2 Diabetes
Jonatan I. Bagger et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes
Kristine J. Hare et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
Traceable Amino Acid Analyses of Proteins and Peptides by Isotope-Dilution Mass Spectrometry Using Precolumn Derivatization Reagent
Tomoya Kinumi et al.
ANALYTICAL SCIENCES (2010)
Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants
Jay M. Sosenko et al.
DIABETES CARE (2010)
Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5)
S. Zampetti et al.
DIABETIC MEDICINE (2010)
Lise G. Heding, 1936-2008
J. Ludvigsson
DIABETOLOGIA (2009)
Latent (Slowly Progressing) Autoimmune Diabetes in Adults
Jochen Seissler
CURRENT DIABETES REPORTS (2008)
Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes
Carla J. Greenbaum et al.
DIABETES CARE (2008)
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults -: Non Insulin Requiring Autoimmune Diabetes (NIRAD) study 3
Antonio Petrone et al.
DIABETES CARE (2008)
A new expression of diabetes: double diabetes
Paolo Pozzilli et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2007)
Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1
JM Sosenko et al.
DIABETES CARE (2006)
Proinsulin levels and the proinsulin:C-peptide ratio complement autoantibody measurement for predicting type 1 diabetes
I Truyen et al.
DIABETOLOGIA (2005)
Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women
MB Schulze et al.
DIABETIC MEDICINE (2005)
Insulin secretion in type 1 diabetes
C Steele et al.
DIABETES (2004)
Insulin resistance, impaired early insulin response, and insulin propeptides as predictors of the development of type 2 diabetes - A population-based, 7-year follow-up study in 70-year-old men
B Zethelius et al.
DIABETES CARE (2004)
Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus - a new surrogate measure of non-progression?
D Schatz et al.
PEDIATRIC DIABETES (2004)
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes
CJ Greenbaum et al.
DIABETES (2003)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Gastric emptying in diabetes: clinical significance and treatment
M Horowitz et al.
DIABETIC MEDICINE (2002)
Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult) - Definition, characterization and potential prevention
P Pozzilli et al.
DIABETES CARE (2001)
Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA)
T Lohmann et al.
DIABETOLOGIA (2001)
Hyperproinsulinemia is not a characteristic feature in the offspring of patients with different phenotypes of type II diabetes
IKJ Vauhkonen et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA)
A Carlsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Share Paper
